238
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Number of Positive Lymph Nodes and Survival in Endometrial Carcinoma: A Proposal for a Modified Staging

, &
Pages 99-109 | Received 31 Aug 2023, Accepted 28 Dec 2023, Published online: 20 Jan 2024

References

  • Gao S, Zhao T, Meng F, Luo Y, Li Y, Wang Y. Circular RNAs in endometrial carcinoma (Review). Oncol Rep. 2022;48(6). doi:10.3892/or.2022.8427
  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer--viewpoint of the IARC working group. N Engl J Med. 2016;375(8):794–798. doi:10.1056/NEJMsr1606602
  • Makker V, MacKay H, Ray-Coquard I, et al. Endometrial cancer. Nat Rev Dis Primers. 2021;7(1):88. doi:10.1038/s41572-021-00324-8
  • Tran L, Christensen P, Barroeta JE, et al. Prognostic significance of size, location, and number of lymph node metastases in endometrial carcinoma. Int J Gynecol Pathol. 2022;42:376–389. doi:10.1097/PGP.0000000000000897
  • Siesto G, Romano F, Iedà NP, Vitobello D. Survival outcomes after surgical management of endometrial cancer: analysis after the first 10-year experience of robotic surgery in a single center. Int J Med Robot. 2020;16(6):1–9. doi:10.1002/rcs.2157
  • Huo X, Wang S. A lymph node count-based AJCC staging system facilitates a more accurate prediction of the prognosis of patients with endometrial cancer. Front Oncol. 2021;11:641962.
  • Kiuchi K, Hasegawa K, Ochiai S, et al. Prognostic significance of inflammatory parameters and nutritional index in clinical stage IVB endometrial carcinomas. J Obstet Gynaecol. 2019;39(2):237–241. doi:10.1080/01443615.2018.1494703
  • McCluggage WG. Pathologic staging of endometrial carcinomas: selected areas of difficulty. Adv Anat Pathol. 2018;25(2):71–84. doi:10.1097/PAP.0000000000000182
  • Ladbury C, Li R, Shiao J, et al. Characterizing impact of positive lymph node number in endometrial cancer using machine-learning: a better prognostic indicator than FIGO staging? Gynecol Oncol. 2022;164(1):39–45. doi:10.1016/j.ygyno.2021.11.007
  • Uccella S, Falcone F, Greggi S, et al. Survival in clinical stage I endometrial cancer with single vs. multiple positive pelvic nodes: results of a multi-institutional Italian study. J Gynecol Oncol. 2018;29(6):e100. doi:10.3802/jgo.2018.29.e100
  • Giuliano AE, Edge SB, Hortobagyi GN. Eighth edition of the AJCC cancer staging manual: breast cancer. Ann Surg Oncol. 2018;25(7):1783–1785. doi:10.1245/s10434-018-6486-6
  • Hemmert R, Schliep KC, Willis S, et al. Modifiable life style factors and risk for incident endometriosis. Paediatr Perinat Epidemiol. 2019;33(1):19–25. doi:10.1111/ppe.12516
  • Liang W, He J, Shen Y, et al. Impact of examined lymph node count on precise staging and long-term survival of resected non-small-cell lung cancer: a population study of the US SEER database and a Chinese multi-institutional registry. J Clin Oncol. 2017;35(11):1162–1170. doi:10.1200/JCO.2016.67.5140
  • Yan G, Li Y, Du Y, Ma X, Xie Y, Zeng X. Survival nomogram for endometrial cancer with lung metastasis: a SEER database analysis. Front Oncol. 2022;12:978140. doi:10.3389/fonc.2022.978140
  • Proppe L, Alkatout I, Koch R, et al. Impact of lymphadenectomy on short- and long-term complications in patients with endometrial cancer. Arch Gynecol Obstet. 2022;306(3):811–819. doi:10.1007/s00404-022-06396-5
  • Min Y, Zhang Z. Hysterectomy or/and lymphadenectomy for the survival of patients with primary endometrial cancer: a cohort study using the SEER database. Biotechnol Genet Eng Rev. 2022;1–19. doi:10.1080/02648725.2022.2162235
  • Capozzi VA, Rosati A, Maglietta G, et al. Long-term survival outcomes in high-risk endometrial cancer patients undergoing sentinel lymph node biopsy alone versus lymphadenectomy. Int J Gynecol Cancer. 2023;2023;1.
  • Pollom EL, Conklin CM, von Eyben R, Folkins AK, Kidd EA. Nomogram to predict risk of lymph node metastases in patients with endometrioid endometrial cancer. Int J Gynecol Pathol. 2016;35(5):395–401. doi:10.1097/PGP.0000000000000246
  • Jamieson A, Thompson EF, Huvila J, et al. Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases. Gynecol Oncol. 2022;165(2):376–384. doi:10.1016/j.ygyno.2022.01.025
  • Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010;375(9721):1165–1172. doi:10.1016/S0140-6736(09)62002-X
  • Havrilesky LJ, Cragun JM, Calingaert B, et al. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol Oncol. 2005;99(3):689–695. doi:10.1016/j.ygyno.2005.07.014
  • Concin N, Matias-Guiu X, Vergote I, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31(1):12–39. doi:10.1136/ijgc-2020-002230
  • Garg V, Jayaraj AS, Kumar L. Novel approaches for treatment of endometrial carcinoma. Curr Probl Cancer. 2022;46(5):100895. doi:10.1016/j.currproblcancer.2022.100895
  • Chan JK, Cheung MK, Huh WK, et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer. 2006;107(8):1823–1830. doi:10.1002/cncr.22185